PTC
ANAC

Private Trust Company’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Private Trust Company’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-45
Closed -$1K – 1811
2014
Q3 		$1K Hold
45
– – ﹤0.01% 1902
2014
Q2 		$1K Hold
45
– – ﹤0.01% 1923
2014
Q1 		$1K Buy
+45
New +$873 ﹤0.01% 1804

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Private Trust Company's ANAC Position: Q4 2014 in Review

Private Trust Company sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2014, closing a stake of 45 shares — an estimated $1K sold.

Private Trust Company first reported a position in ANAC in Q1 2014 and held it in 3 quarters. The position peaked at $1K in Q3 2014. 147 funds tracked by Wall St. Rank hold ANAC as of Q4 2014.

  • Private Trust Company reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2014 after selling out during the quarter.
  • Private Trust Company sold 45 ANACOR PHARMACEUTICALS INC COM shares in Q4 2014, an estimated $1K.
  • Private Trust Company first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 3 quarters.
  • Private Trust Company's ANACOR PHARMACEUTICALS INC COM position peaked at $1K in Q3 2014.
  • 147 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.